TELA Bio (TELA) Research & Development (2018 - 2026)

TELA Bio has reported Research & Development for 9 years, with the latest figure at $16.4 million in Q2 2026.

• On a quarterly basis, Research & Development fell 2.46% year-over-year to $16.4 million in Q2 2026; TTM through Jun 2026 was $62.7 million, a 1.87% decrease from a year earlier, with the FY2025 full-year figure at $63.2 million, down 2.27% from the prior year.
• Research & Development was $16.4 million for Q2 2026 at TELA Bio, down from $16.5 million in the prior quarter.
• The five-year high for Research & Development was $17.5 million in Q1 2024, with the low at $9.4 million in Q1 2022.
• Average Research & Development over 5 years is $14.7 million, with a median of $14.9 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Research & Development jumped 60.79% in 2022, then dropped 18.68% in 2024.
• Over 5 years, Research & Development stood at $11.6 million in 2022, then soared by 47.37% to $17.2 million in 2023, then slipped by 18.68% to $14.0 million in 2024, then grew by 3.82% to $14.5 million in 2025, then advanced by 13.47% to $16.4 million in 2026.
• The last three Research & Development figures came in at $16.4 million (Q2 2026), $16.5 million (Q1 2026), and $14.5 million (Q4 2025), per Business Quant data.